Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects.

导出 LinkOut

翻译打印收藏纠错

作者： Yuta,Takagaki ^[1] ; Daisuke,Koya ; Keizo,Kanasaki

作者单位： aDepartment of Diabetology and Endocrinology bDivision of Anticipatory Molecular Food Science and Technology, Kanazawa Medical University, Uchinada, Ishikawa, Japan. ^[1]

主题词动物(Animals);二肽基肽酶4(Dipeptidyl Peptidase 4);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);内皮细胞(Endothelial Cells);上皮-间质转化(Epithelial-Mesenchymal Transition);纤维化(Fibrosis);人类(Humans);降血糖药(Hypoglycemic Agents);肾(Kidney);肾疾病(Kidney Diseases)

DOI 10.1097/MNH.0000000000000291

PMID 27820706

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览20

Current opinion in nephrology and hypertension

2017年26卷1期

56-66页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects.

Current opinion in nephrology and hypertension

相似文献

Current opinion in nephrology and hypertension

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects.

Current opinion in nephrology and hypertension

相似文献

Current opinion in nephrology and hypertension

相关期刊

检索历史清除